News AstraZeneca PLC Xetra

Equities

ZEG

GB0009895292

Real-time Estimate Tradegate Other stock markets 05:47:20 2024-05-20 EDT			5-day change	1st Jan Change
141.1 ^EUR	-0.34%		-1.54%	+15.48%

11:25am	European Midday Briefing : Stocks, Commodities Gain on Fresh China Policy Support	DJ
10:47am	AstraZeneca: Phase 2 endpoint not met in COPD	CF

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

European Midday Briefing : Stocks, Commodities Gain on Fresh China Policy Support	05:25am	DJ
AstraZeneca: Phase 2 endpoint not met in COPD	04:47am	CF
European stocks start the week on a high	04:39am
AstraZeneca to Build $1.5 Billion Cancer Therapy Manufacturing Facility in Singapore	04:24am	MT
AstraZeneca: new production facility in Singapore	04:18am	CF
AstraZeneca plans to build manufacturing plant in Singapore	03:26am	AN
Keywords would back GBP2.0 billion bid as EQT circles	02:50am	AN
AstraZeneca Plans $1.5 Billion Manufacturing Facility in Singapore	02:49am	DJ
AstraZeneca to Develop $1.5 Billion Singapore Manufacturing Facility	02:30am	MT
Correction: AstraZeneca Ordered to Pay $108 Million to Pfizer for Patent Violations	02:25am	MT
AstraZeneca to build $1.5-bln cancer drug plant in Singapore	02:17am	RE
AstraZeneca plans to build $1.5 billion manufacturing facility in Singapore	02:17am	RE
AstraZeneca Ordered to Pay $108 Million to Pfizer for Patent Violations	02:15am	MT
New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease	05-19	BU
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial	05-17	RE
AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial	05-16	MT
Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon...	05-16
AlzeCure Pharma AB - Eli Lilly's and AstraZeneca's former head of research Dr. Jan Lundberg elected as a new board member	05-16	AQ
AstraZeneca : SUPERNOVA Phase III trial of sipavibart long-acting antibody met primary endpoints in preventing COVID-19 in immunocompromised patient population - Form 6-K	05-16	PU
AstraZeneca trials yield positive results for immunocompromised patients	05-16	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm